RxDoctor Payments DataLook up a doctor →

Vadim Koshkin, MD

Internal Medicine · Cleveland, OHNPI 1154684777

Payments from drug & device makers

$6,099,838in general payments, 2019–2025

Across 482 payments — averaging $12,655 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$2M
  • Taiho Oncology, Inc.$1.7M
  • Pfizer$601K
  • Seagen Inc.$426K
  • Lilly USA, LLC$341K
  • Astellas US Technologies$281K
  • plus $753K from 23 others
$3,051in research payments, 2019–2025

Across 9 payments — averaging $338.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Seagen Inc.$2K
  • Pfizer$1K
  • Gilead$60

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,099,838 in reported general payments places this provider in the 95th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$190,859
Medicare patients
189
Services billed
3,908

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →